207 related articles for article (PubMed ID: 34819673)
1. Mechanism for the activation of the anaplastic lymphoma kinase receptor.
Reshetnyak AV; Rossi P; Myasnikov AG; Sowaileh M; Mohanty J; Nourse A; Miller DJ; Lax I; Schlessinger J; Kalodimos CG
Nature; 2021 Dec; 600(7887):153-157. PubMed ID: 34819673
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of cytokine-mediated activation of ALK family receptors.
De Munck S; Provost M; Kurikawa M; Omori I; Mukohyama J; Felix J; Bloch Y; Abdel-Wahab O; Bazan JF; Yoshimi A; Savvides SN
Nature; 2021 Dec; 600(7887):143-147. PubMed ID: 34646012
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for ligand reception by anaplastic lymphoma kinase.
Li T; Stayrook SE; Tsutsui Y; Zhang J; Wang Y; Li H; Proffitt A; Krimmer SG; Ahmed M; Belliveau O; Walker IX; Mudumbi KC; Suzuki Y; Lax I; Alvarado D; Lemmon MA; Schlessinger J; Klein DE
Nature; 2021 Dec; 600(7887):148-152. PubMed ID: 34819665
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.
Huang H
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400214
[TBL] [Abstract][Full Text] [Related]
6. Dermatan sulphate is an activating ligand of anaplastic lymphoma kinase.
Machino M; Gong Y; Ozaki T; Suzuki Y; Watanabe E; Imagama S; Kadomatsu K; Sakamoto K
J Biochem; 2021 Dec; 170(5):631-637. PubMed ID: 34270745
[TBL] [Abstract][Full Text] [Related]
7. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
Guan J; Umapathy G; Yamazaki Y; Wolfstetter G; Mendoza P; Pfeifer K; Mohammed A; Hugosson F; Zhang H; Hsu AW; Halenbeck R; Hallberg B; Palmer RH
Elife; 2015 Sep; 4():e09811. PubMed ID: 26418745
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
[TBL] [Abstract][Full Text] [Related]
9. ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Borenäs M; Umapathy G; Lai WY; Lind DE; Witek B; Guan J; Mendoza-Garcia P; Masudi T; Claeys A; Chuang TP; El Wakil A; Arefin B; Fransson S; Koster J; Johansson M; Gaarder J; Van den Eynden J; Hallberg B; Palmer RH
EMBO J; 2021 Feb; 40(3):e105784. PubMed ID: 33411331
[TBL] [Abstract][Full Text] [Related]
10. The neuronal tyrosine kinase receptor ligand ALKAL2 mediates persistent pain.
Defaye M; Iftinca MC; Gadotti VM; Basso L; Abdullah NS; Cuménal M; Agosti F; Hassan A; Flynn R; Martin J; Soubeyre V; Poulen G; Lonjon N; Vachiery-Lahaye F; Bauchet L; Mery PF; Bourinet E; Zamponi GW; Altier C
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35608912
[TBL] [Abstract][Full Text] [Related]
11. Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.
Moog-Lutz C; Degoutin J; Gouzi JY; Frobert Y; Brunet-de Carvalho N; Bureau J; Créminon C; Vigny M
J Biol Chem; 2005 Jul; 280(28):26039-48. PubMed ID: 15886198
[TBL] [Abstract][Full Text] [Related]
12. Targeting anaplastic lymphoma kinase in neuroblastoma.
Umapathy G; Mendoza-Garcia P; Hallberg B; Palmer RH
APMIS; 2019 May; 127(5):288-302. PubMed ID: 30803032
[TBL] [Abstract][Full Text] [Related]
13. Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α).
Reshetnyak AV; Mohanty J; Tomé F; Puleo DE; Plotnikov AN; Ahmed M; Kaur N; Poliakov A; Cinnaiyan AM; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):8340-8345. PubMed ID: 30061385
[TBL] [Abstract][Full Text] [Related]
14. Role and targeting of anaplastic lymphoma kinase in cancer.
Della Corte CM; Viscardi G; Di Liello R; Fasano M; Martinelli E; Troiani T; Ciardiello F; Morgillo F
Mol Cancer; 2018 Feb; 17(1):30. PubMed ID: 29455642
[TBL] [Abstract][Full Text] [Related]
15. Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration.
Huang H; Gont A; Kee L; Dries R; Pfeifer K; Sharma B; Debruyne DN; Harlow M; Sengupta S; Guan J; Yeung CM; Wang W; Hallberg B; Palmer RH; Irwin MS; George RE
Cell Rep; 2021 Jul; 36(2):109363. PubMed ID: 34260934
[TBL] [Abstract][Full Text] [Related]
16. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.
Murray PB; Lax I; Reshetnyak A; Ligon GF; Lillquist JS; Natoli EJ; Shi X; Folta-Stogniew E; Gunel M; Alvarado D; Schlessinger J
Sci Signal; 2015 Jan; 8(360):ra6. PubMed ID: 25605972
[TBL] [Abstract][Full Text] [Related]
17. ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells.
Fadeev A; Mendoza-Garcia P; Irion U; Guan J; Pfeifer K; Wiessner S; Serluca F; Singh AP; Nüsslein-Volhard C; Palmer RH
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E630-E638. PubMed ID: 29317532
[TBL] [Abstract][Full Text] [Related]
18. Conformational Transition of Key Structural Features Involved in Activation of ALK Induced by Two Neuroblastoma Mutations and ATP Binding: Insight from Accelerated Molecular Dynamics Simulations.
He MY; Li WK; Zheng QC; Zhang HX
ACS Chem Neurosci; 2018 Jul; 9(7):1783-1792. PubMed ID: 29638111
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
Katic L; Priscan A
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892172
[TBL] [Abstract][Full Text] [Related]
20. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.
Bischof D; Pulford K; Mason DY; Morris SW
Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
